Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : TGL WHAAAAAAAT! Alerts, thoughts, discussion. -- Ignore unavailable to you. Want to Upgrade?

To: SSP who wrote (19040)	1/5/2000 4:39:00 PM
From: Jim Bishop	Read Replies (2) \| Respond to of 150070

HICS I didn't get a chance to post, I got in at .13 while I was on the phone with the CEO Charles Kallmann, 877/994-9376. He tells me o/s is about 11MM, that the structure of the SB-2 filing is not yet determined, but will be at the shareholders meeting either Jan 15 or 18, I didn't catch which. While it will be dilutive, he says it will NOT be a convertible debenture, but suggested I call the fellow at I believe National Capital, which I gather are the investment bankers on this deal. I have that name and number if anyone wants it. The news from today states: "The Company intends to offer this patentable formulation on a license arrangement to manufacturers of china, glass, cooking utensils, as well as application to table surfaces. Hydrogiene believes these license arrangements offer national and international potential with major cash flow generation implications. SB-2 funds will be used for advertising and promoting co-op activities in concert with its major retail outlets. The five million dollars in question, is at this time committed to by a local Irvine, California investor group. Kallmann also announced that life cycle testing of its Theraclenze and Mediclenze Systems recently concluded having passed a 500,000 life cycle testing without failure. U.L. and IAPMO certification is expected shortly. He is very excited about their product, and I can see why. I'll do some more checking into it later, but he does say that as well as it having no competition, it is socially, and heathwise, enormously beneficial There are more news releases coming, positive revenues numbers by March, fully reporting, he expects to split the stock 2 for 1 within six months, says he's not an expert on this public company stuff, he's a businessman charged with growing shareholder value for what he believes is now about 700 shareholders. He leaves the stock stuff up to the experts.